Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (361-370 of 487) with videos related to

Pageof 49
Sort By:
British Journal of Haematology|April 12, 2001
A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpuraG C Newman, M V Novoa, E M Fodero, et al.
American Journal of Hematology|September 26, 2022
Romiplostim use in pregnant women with immune thrombocytopeniaJames B Bussel, Nichola Cooper, Tatiana Lawrence, et al.
Obstetrics and Gynecology|January 6, 2006
Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopeniaRichard L Berkowitz, E Anders Kolb, Janice G McFarland, et al.
The New England Journal of Medicine|May 8, 1986
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibodyS B Clarkson, J B Bussel, R P Kimberly, et al.
The Journal of Experimental Medicine|June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceMaxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
Revue Neurologique|May 2, 2002
[Double dissociation between unilateral neglect and anosognosia]V Dauriac-Le Masson, L Mailhan, A Louis-Dreyfus, et al.
Neurology|October 25, 2006
Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticityD Bensmail, M A Quera Salva, N Roche, et al.
Haematologica|January 28, 2014
Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-upWaleed Ghanima, Julia Turbiner Geyer, Christina S Lee, et al.
British Journal of Haematology|April 3, 2004
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
British Journal of Haematology|August 30, 2021
Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND studyOliver Meyer, Raymond S M Wong, Abderrahim Khelif, et al.
Pageof 49

Showing results (361-370 of 487) with videos related to

Sort By:
Pageof 49
British Journal of Haematology|April 12, 2001
A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpuraG C Newman, M V Novoa, E M Fodero, et al.
American Journal of Hematology|September 26, 2022
Romiplostim use in pregnant women with immune thrombocytopeniaJames B Bussel, Nichola Cooper, Tatiana Lawrence, et al.
Obstetrics and Gynecology|January 6, 2006
Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopeniaRichard L Berkowitz, E Anders Kolb, Janice G McFarland, et al.
The New England Journal of Medicine|May 8, 1986
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibodyS B Clarkson, J B Bussel, R P Kimberly, et al.
The Journal of Experimental Medicine|June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceMaxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
Revue Neurologique|May 2, 2002
[Double dissociation between unilateral neglect and anosognosia]V Dauriac-Le Masson, L Mailhan, A Louis-Dreyfus, et al.
Neurology|October 25, 2006
Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticityD Bensmail, M A Quera Salva, N Roche, et al.
Haematologica|January 28, 2014
Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-upWaleed Ghanima, Julia Turbiner Geyer, Christina S Lee, et al.
British Journal of Haematology|April 3, 2004
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
British Journal of Haematology|August 30, 2021
Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND studyOliver Meyer, Raymond S M Wong, Abderrahim Khelif, et al.
Pageof 49